Roche expects cancer treatments to be spared U.S. pricing curbs

BASEL, Switzerland (Reuters) - The U.S. Congress may intervene on how much companies can charge for some drugs following a move last year by Turing Pharmaceuticals to ratchet up the price of a treatment for deadly parasite infections by 5,000 percent, Roche's head of pharmaceuticals said.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro